Search This Blog

Friday, February 15, 2019

Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation

According to a post on the FDA’s website, Amgen’s treatment of Acute Myeloid Leukemia was granted orphan designation.
https://thefly.com/landingPageNews.php?id=2865695
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)